Bone Changes During Growth in Patients with Osteogenesis Imperfecta

被引:0
|
作者
Burgueno-Torres, Laura [1 ]
Garcia-Boedo, Lara [1 ]
de Nova-Garcia, Manuel Joaquin [1 ]
机构
[1] Univ Complutense Madrid, Fac Dent, Dent Clin Specialties Dept, Madrid 28040, Spain
关键词
osteogenesis imperfecta; biphosphonates; orthopantomography; panoramic index; pediatric patient; PANORAMIC MANDIBULAR INDEXES; RADIOMORPHOMETRIC INDEXES; FRACTAL DIMENSION; CHILDREN; PAMIDRONATE; THERAPY; DENSITY; DIAGNOSIS; GENDER; CORTEX;
D O I
10.3390/jcm14051764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Objectives: Osteogenesis Imperfecta (OI) is a congenital disorder, in which the production of collagen, mainly type I, is altered, leading to a decrease in bone mineral density, increasing the risk of fracture with minimal trauma. Several studies have analyzed bone mineral density in osteoporotic patients based on linear measurements such as radiomorphometric indices measured with panoramic radiographs, although few studies have investigated bone trabeculation in children diagnosed with OI. Therefore, the aim of the present investigation was to analyze the dental panoramic indices in panoramic radiographs in the cortical and trabeculated bone of children with OI. Methods: Thus, 66 pediatric patients diagnosed with OI under antiresorptive treatment were compared with a sample of controls matched for sex and age. Using Image J software (version: 1.54d), three radiomorphometric indices were analyzed in orthopantomographies of the study and control groups, evaluating the influence of disease severity as well as the type of antiresorptive treatment administered. Results: Patients with OI had a higher presence of type C2 and C3 MCI (mandibular cortical index) than their matched controls (p < 0.05), although no differences were found for the visual estimation of cortical width (SVE) and mandibular cortical width (MCW). Treatment with zoledronic acid was associated with a higher number of cases of type C1 MCI, in terms of sample description, while patients treated with a combination of pamidronate and zoledronic acid had a higher rate of type C1 and C2 MCI, with no statistical differences. Conclusions: In the overall sample, most patients showed a thin SVE index (59.1%), a C2 or C1 type MCI (46.2% and 42.4%) and an MCW of 2.9 mm. Differences in bone mineral density were also observed throughout growth and the different antiresorptive treatments. Zoledronic acid has been associated with a higher percentage of C1 and C3 ICM, and pamidronate alone or in combination is associated with a C1 and C2 MCI index.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] OSTEOGENESIS IMPERFECTA - CHANGES IN NONCOLLAGENOUS PROTEINS IN BONE
    VETTER, U
    FISHER, LW
    MINTZ, KP
    KOPP, JB
    TUROSS, N
    TERMINE, JD
    ROBEY, PG
    JOURNAL OF BONE AND MINERAL RESEARCH, 1991, 6 (05) : 501 - 505
  • [2] Growth and Puberty in Patients with Osteogenesis Imperfecta
    Ozturk, Ayse Pinar
    Ozturan, Esin Karakilic
    Poyrazoglu, Sukran
    Bas, Firdevs
    Darendeliler, Feyza
    HORMONE RESEARCH IN PAEDIATRICS, 2021, 94 (SUPPL 1): : 94 - 95
  • [3] Craniofacial Bone Mineral Density During Growth in Mice with Osteogenesis Imperfecta (OI)
    Miller, Courtney
    Wright, Tommy
    McBride, Alexandra
    Organ, Jason
    Menegaz, Rachel
    FASEB JOURNAL, 2021, 35
  • [4] Bone turnover markers in patients with Osteogenesis Imperfecta
    Adami, S
    Braga, V
    Gatti, D
    Colapietro, F
    Rossini, M
    Battaglia, L
    Bakri, J
    Prizzi, R
    Fuggetta, EM
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S16 - S16
  • [5] Collagen and bone markers in patients with osteogenesis imperfecta
    Brenner, RE
    PAEDIATRIC OSTEOLOGY: NEW DEVELOPMENTS IN DIAGNOSTICS AND THERAPY, 1996, 1105 : 221 - 226
  • [6] Bone turnover markers in patients with osteogenesis imperfecta
    Braga, V
    Gatti, D
    Rossini, M
    Colapietro, F
    Battaglia, E
    Viaplana, O
    Adami, S
    BONE, 2004, 34 (06) : 1013 - 1016
  • [7] Mechanisms of Bone Fragility with Skeletal Growth in Osteogenesis Imperfecta
    Docaj, Anxhela
    Munoz, Asier
    Carriero, Alessandra
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 252 - 253
  • [8] Sclerostin Antibody induces changes in Osteogenesis Imperfecta craniofacial bone
    Sung, Hsiao
    Terner, Braden
    Eun, Hane
    Davidson, Esmeralda Blaney
    Kozloff, Kenneth
    JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 403 - 404
  • [9] Unexpected ultrastructral changes in bone osteiod collagens in osteogenesis imperfecta
    Sarathchandra, P
    Pope, FM
    MICRON, 2005, 36 (7-8) : 696 - 702
  • [10] Study of Bone Metabolism in Patients Diagnosed with Osteogenesis Imperfecta
    Ramos Castro, Daniel
    Leal, Samuel
    Grau Garcia, Elena
    Oller Rodriguez, Jose Eloy
    Ivorra-Cortes, Jose
    Riesco Barcena, Carmen
    Huaylla Quispe, Anderson
    Munoz Martinez, Pablo
    Mas Sanchez, Laura
    Torrat Noves, Alba
    Villanueva Manes, Belen
    Alcantara Alvarez, Iago
    Perez Hurtado, Andres
    Simeo Vinaixa, Miguel
    Roman-Ivorra, Jose A.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4331 - 4333